|
Delayed
Hong Kong S.E.
22:38:20 2026-08-13 EDT
|
5-day change | 1st Jan Change | ||
| 0.4300 HKD | +1.18% |
|
-3.37% | -27.12% |
| 06-29 | EC Healthcare Reports Earnings Results for the Full Year Ended March 31, 2026 | CI |
| 06-25 | EC Healthcare Forecasts Wider Full-Year Loss | MT |
Company Valuation: EC Healthcare
Data adjusted to current consolidation scope
| Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 7,261 | 9,828 | 7,431 | 1,553 | 817.8 | 545.2 |
| Change | - | 35.34% | -24.38% | -79.11% | -47.33% | -33.33% |
| Enterprise Value (EV) 1 | 7,328 | 9,853 | 8,203 | 2,522 | 1,068 | 793.4 |
| Change | - | 34.45% | -16.74% | -69.26% | -57.66% | -25.7% |
| P/E | 36.3x | 49.6x | 106x | -81.9x | -4.89x | -1.35x |
| PBR | 5.72x | 5.22x | 4.01x | 0.79x | 0.46x | 0.39x |
| PEG | - | -4.9x | -1.6x | 1x | -0x | -0x |
| Capitalization / Revenue | 3.49x | 3.37x | 1.92x | 0.37x | 0.2x | 0.14x |
| EV / Revenue | 3.52x | 3.37x | 2.12x | 0.6x | 0.26x | 0.21x |
| EV / EBITDA | 24.5x | 19.6x | 23.3x | 6.41x | 2.95x | 3.19x |
| EV / EBIT | 38.7x | 29.7x | 68.9x | 23.1x | 38.5x | 103x |
| EV / FCF | 18.3x | 21.8x | 18.6x | 11.2x | 1.91x | 1.97x |
| FCF Yield | 5.48% | 4.58% | 5.36% | 8.93% | 52.3% | 50.8% |
| Dividend per Share 2 | 0.159 | 0.144 | 0.1 | 0.005 | 0.01 | - |
| Rate of return | 2.35% | 1.73% | 1.59% | 0.38% | 1.45% | - |
| EPS 2 | 0.187 | 0.168 | 0.059 | -0.016 | -0.1411 | -0.3398 |
| Distribution rate | 85% | 85.7% | 169% | -31.3% | -7.09% | - |
| Net sales 1 | 2,080 | 2,920 | 3,875 | 4,211 | 4,140 | 3,770 |
| EBITDA 1 | 298.8 | 502.4 | 352.1 | 393.2 | 361.6 | 249 |
| EBIT 1 | 189.3 | 331.7 | 119 | 109 | 27.72 | 7.72 |
| Net income 1 | 192.9 | 197.5 | 69.65 | -18.95 | -167.2 | -402.7 |
| Net Debt 1 | 66.9 | 25.37 | 772.1 | 969.2 | 250 | 248.2 |
| Reference price 2 | 6.7800 | 8.3400 | 6.2700 | 1.3100 | 0.6900 | 0.4600 |
| Nbr of stocks (in thousands) | 1,071,016 | 1,178,372 | 1,185,211 | 1,185,211 | 1,185,211 | 1,185,211 |
| Announcement Date | 7/23/21 | 7/25/22 | 7/25/23 | 7/31/24 | 7/31/25 | 7/30/26 |
1HKD in Million2HKD
Estimates
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 63.43M | |
| 8.97x | 1.22x | 5.19x | 5.39% | 614M | |
| 13.46x | - | - | 4.32% | 124M | |
| 18.93x | 2.71x | 7.55x | 2.83% | 123M | |
| 14.76x | - | - | 3.03% | 112M | |
| Average | 14.03x | 1.96x | 6.37x | 3.89% | 207.47M | |
| Weighted average by Cap. | 11.47x | 1.47x | 5.59x | 4.66% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 2138 Stock
- Valuation EC Healthcare
Select your edition
All financial news and data tailored to specific country editions
